Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000215789

Medchemexpress LLC N-[(6,7-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 g/mol | C23H19F3N8O | 10 MG
SDP

Supplier:  Medchemexpress LLC HY10001110MG

Encompass_Preferred

SR-3029 is a potent, ATP-competitive small-molecule inhibitor of casein kinase 1 delta (CK1δ) and epsilon (CK1ε) used as a research reagent in biochemical and cell-based studies. It shows low-nanomolar activity against CK1δ and selective activity against CK1ε, with additional reported activity across certain CDKs and FLT3 in kinase profiling.

  • Potent ATP-competitive inhibition of CK1δ and CK1ε (IC50 44 nM and 260 nM).
  • Ki of 97 nM for both CK1δ and CK1ε.
  • High purity suitable for biochemical and cell-based assays.
  • Available in multiple solid sizes and as DMSO solution for assay preparation.
  • Supplied as a white to pink solid for ease of handling and storage.
  • Molecular weight 480.45 g/mol, facilitating dose calculation.
  • For research use only; not for human or clinical use.

Catalog No. 50-002-15789


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.